In pancreatic cancer, high PCDH17 expression associates with elevated inflammatory factors (TGF-β, IL6-JAK-STAT3, TNFA pathways) and enhanced immune activity, including antigen presentation and T-cell recruitment. This evidence concerns the gene IL6 and familial pancreatic carcinoma.